Both CD63 and NCAM-L1 were expressed in the total EX fraction (initial ExoQuick precipitate) and the NEX fraction (after immuno-enrichment) from the serum of AD patients and CTL subjects (Figure S2D). Here, CD63 is linked to Alzheimer disease.